These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501 [TBL] [Abstract][Full Text] [Related]
49. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3. Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582 [TBL] [Abstract][Full Text] [Related]
50. Up-regulated WDR5 promotes gastric cancer formation by induced cyclin D1 expression. Sun W; Guo F; Liu M J Cell Biochem; 2018 Apr; 119(4):3304-3316. PubMed ID: 29125890 [TBL] [Abstract][Full Text] [Related]
51. The p53 pathway and its inactivation in neuroblastoma. Tweddle DA; Pearson AD; Haber M; Norris MD; Xue C; Flemming C; Lunec J Cancer Lett; 2003 Jul; 197(1-2):93-8. PubMed ID: 12880966 [TBL] [Abstract][Full Text] [Related]
52. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells. Lutz W; Schwab M Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765 [TBL] [Abstract][Full Text] [Related]
53. A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF. Iraci N; Diolaiti D; Papa A; Porro A; Valli E; Gherardi S; Herold S; Eilers M; Bernardoni R; Della Valle G; Perini G Cancer Res; 2011 Jan; 71(2):404-12. PubMed ID: 21123453 [TBL] [Abstract][Full Text] [Related]
54. Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma. Van Maerken T; Speleman F; Vermeulen J; Lambertz I; De Clercq S; De Smet E; Yigit N; Coppens V; Philippé J; De Paepe A; Marine JC; Vandesompele J Cancer Res; 2006 Oct; 66(19):9646-55. PubMed ID: 17018622 [TBL] [Abstract][Full Text] [Related]
55. Zimmerman MW; Liu Y; He S; Durbin AD; Abraham BJ; Easton J; Shao Y; Xu B; Zhu S; Zhang X; Li Z; Weichert-Leahey N; Young RA; Zhang J; Look AT Cancer Discov; 2018 Mar; 8(3):320-335. PubMed ID: 29284669 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835 [TBL] [Abstract][Full Text] [Related]
57. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma. Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046 [TBL] [Abstract][Full Text] [Related]
58. Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification. Liu X; Mazanek P; Dam V; Wang Q; Zhao H; Guo R; Jagannathan J; Cnaan A; Maris JM; Hogarty MD Oncogene; 2008 Feb; 27(10):1478-88. PubMed ID: 17724465 [TBL] [Abstract][Full Text] [Related]
59. The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines. Rorie CJ; Weissman BE Cancer Res; 2004 Oct; 64(20):7288-95. PubMed ID: 15492248 [TBL] [Abstract][Full Text] [Related]
60. Analysis of Myc-induced histone modifications on target chromatin. Martinato F; Cesaroni M; Amati B; Guccione E PLoS One; 2008; 3(11):e3650. PubMed ID: 18985155 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]